Social Markers of Mild Cognitive Impairment: Proportion of Word Counts in Free Conversational Speech

Hiroko H Dodge, Nora Mattek, Mattie Gregor, Molly Bowman, Adriana Seelye, Oscar Ybarra, Meysam Asgari, Jeffrey A Kaye, Hiroko H Dodge, Nora Mattek, Mattie Gregor, Molly Bowman, Adriana Seelye, Oscar Ybarra, Meysam Asgari, Jeffrey A Kaye

Abstract

Background: Detecting early signs of Alzheimer's disease (AD) and mild cognitive impairment (MCI) during the pre-symptomatic phase is becoming increasingly important for costeffective clinical trials and also for deriving maximum benefit from currently available treatment strategies. However, distinguishing early signs of MCI from normal cognitive aging is difficult. Biomarkers have been extensively examined as early indicators of the pathological process for AD, but assessing these biomarkers is expensive and challenging to apply widely among pre-symptomatic community dwelling older adults. Here we propose assessment of social markers, which could provide an alternative or complementary and ecologically valid strategy for identifying the pre-symptomatic phase leading to MCI and AD.

Methods: The data came from a larger randomized controlled clinical trial (RCT), where we examined whether daily conversational interactions using remote video telecommunications software could improve cognitive functions of older adult participants. We assessed the proportion of words generated by participants out of total words produced by both participants and staff interviewers using transcribed conversations during the intervention trial as an indicator of how two people (participants and interviewers) interact with each other in one-on-one conversations. We examined whether the proportion differed between those with intact cognition and MCI, using first, generalized estimating equations with the proportion as outcome, and second, logistic regression models with cognitive status as outcome in order to estimate the area under ROC curve (ROC AUC).

Results: Compared to those with normal cognitive function, MCI participants generated a greater proportion of words out of the total number of words during the timed conversation sessions (p=0.01). This difference remained after controlling for participant age, gender, interviewer and time of assessment (p=0.03). The logistic regression models showed the ROC AUC of identifying MCI (vs. normals) was 0.71 (95% Confidence Interval: 0.54 - 0.89) when average proportion of word counts spoken by subjects was included univariately into the model.

Conclusion: An ecologically valid social marker such as the proportion of spoken words produced during spontaneous conversations may be sensitive to transitions from normal cognition to MCI.

References

    1. Dodge H.H., Ybarra O., Kaye J.A. Tools for advancing research into social networks and cognitive function in older adults. Int. Psychogeriatr. 2014;26:533–539.
    1. Roark B., Mitchell M., Hosom J.P., Hollingshead K., Kaye J. Spoken language derived measures for detecting mild cognitive impairment. IEEE Trans. Audio Speech Lang. Process. 2011;19:2081–2090.
    1. Kanai R., Bahrami B., Roylance R., Rees G. Online social network size is reflected in human brain structure. Proc. Biol. Sci. 2012;279:1327–1334.
    1. Satt A, Sorin A, Toledo-Ronen O, Barkan O, Kompatsiaris I, Kokonozi A, et al. Evaluation of speech-based protocol for detection of early-stage dementia. 2013.
    1. Dodge H.H., Zhu J., Mattek N., Bowman M., Ybarra O., Wild K., et al. A 6-week randomized controlled trial to increase social interactions using home-based technologies improved language-based executive function. Alzheimer Dementia: Trans Res Clin Intervent. 2015;1:1–12.
    1. Dodge H.H., Zhu J., Mattek N., Bowman B.A., Gregor B.A., et al. Characteristics associated with willingness to participate in a randomized controlled behavioral clinical trial using home-based personal computers and a webcam. Trials. 2014;15:508.
    1. Schmitter-Edgecombe M., Woo E., Greeley D.R. Characterizing multiple memory deficits and their relation to everyday functioning in individuals with mild cognitive impairment. Neuropsychology. 2009;23:168–177.
    1. Kaye J., Mattek N., Dodge H.H., Campbell I., Hayes T., Austin D., et al. Unobtrusive measurement of daily computer use to detect mild cognitive impairment. Alzheimers Dement. 2013;10:10–17.
    1. Dodge H.H., Mattek N.C., Austin D., Hayes T.L., Kaye J.A. In-home walking speeds and variability trajectories associated with mild cognitive impairment. Neurology. 2012;78:1946–1952.
    1. Hayes T.L., Hunt J.M., Adami A., Kaye J.A. An electronic pillbox for continuous monitoring of medication adherence. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2006;1:6400–6403.
    1. Hayes T.L., Larimer N., Adami A., Kaye J.A. Medication adherence in healthy elders: small cognitive changes make a big difference. J. Aging Health. 2009;21:567–580.
    1. Petersen J., Austin D., Kaye J.A., Pavel M., Hayes T.L. Unobtrusive in-home detection of time spent out-of-home with applications to loneliness and physical activity. IEEE J. Biomed. Health Inform. 2014;18:1590–1596.
    1. Kaye J.A., Maxwell S.A., Mattek N., Hayes T.L., Dodge H., Pavel M., et al. Intelligent systems for assessing aging changes: home-based, unobtrusive, and continuous assessment of aging. J. Gerontol. B Psychol. Sci. Soc. Sci. 2011;66(1):i180–i190.
    1. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412–2414.
    1. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159–1165.
    1. Lezak M.D., Howieson D.B., Bigler E.D., Tranel D. Neuropsychological Asessment. New York: Oxford University Press; 2012.
    1. Reitan R.M. Validity of the Trail-making Tests as an indication of organic brain damage. Percept. Mot. Skills. 1985;8:271–276.
    1. Jastak S, Wilkinson G. The Wide Range Achievement Test- Revised Willmington: Jastak Associates, Inc. 1984.
    1. Folstein M.F., Folstein S.E., McHugh P.R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189–198.
    1. Ybarra O., Burnstein E., Winkielman P., Keller M.C., Manis M., Chan E., et al. Mental exercising through simple socializing: social interaction promotes general cognitive functioning. Pers. Soc. Psychol. Bull. 2008;34:248–259.
    1. Ybarra O., Winkielman P. On-line social interactions and executive functions. Front. Hum. Neurosci. 2012;6:75.
    1. Kemper S., McDowd J. Dimensions of Cognitive Aging: Executive Function and Verbal Fluency. Handbook of Cognitive Aging: Interdisciplinary perspectives. Thousand Oaks, CA: Sage; 2008.
    1. Berisha V., Wang S., LaCross A., Liss J. Tracking discourse complexity preceding Alzheimer's disease diagnosis: a case study comparing the press conferences of presidents ronald reagan and george herbert walker bush. J. Alzheimers Dis. 2015;45:959–963.
    1. Apostolova L.G., Hwang K.S., Kohannim O., Avila D., Elashoff D., Jack C.R., Jr, et al. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease. Neuroimage Clin. 2014;4:461–472.
    1. Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, et al. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement. 2014;10:799–807.
    1. Perrin R.J., Craig-Schapiro R., Malone J.P., Shah A.R., Gilmore P., Davis A.E., et al. Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One. 2011;6:e16032.
    1. Mapstone M., Cheema A.K., Fiandaca M.S., Zhong X., Mhyre T.R., MacArthur L.H., et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat. Med. 2014;20:415–418.
    1. Jak A.J., Bondi M.W., Delano-Wood L., Wierenga C., Corey-Bloom J., Salmon D.P., et al. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am. J. Geriatr. Psychiatry. 2009;17:368–375.
    1. Kaplan E.F., Goodglass H., Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger; 1983.
    1. Cerhan J.H., Ivnik R.J., Smith G.E., Tangalos E.C., Petersen R.C., Boeve B.F. Diagnostic utility of letter fluency, category fluency, and fluency difference scores in Alzheimer's disease. Clin. Neuropsychol. 2002;16:35–42.
    1. Henry J.D., Crawford J.R., Phillips L.H. Verbal fluency performance in dementia of the Alzheimer's type: a meta-analysis. Neuropsychologia. 2004;42:1212–1222.
    1. Brandt J., Manning K.J. Patterns of word-list generation in mild cognitive impairment and Alzheimer's disease. Clin. Neuropsychol. 2009;23:870–879.
    1. Appell J., Kertesz A., Fisman M. A study of language functioning in Alzheimer patients. Brain Lang. 1982;17:73–91.
    1. Rueda A.D., Schmitter-Edgecombe M. Time estimation abilities in mild cognitive impairment and Alzheimer's disease. Neuropsychology. 2009;23:178–188.
    1. Baglio F., Castelli I., Alberoni M., Blasi V., Griffanti L., Falini A., et al. Theory of mind in amnestic mild cognitive impairment: an FMRI study. JAD. 2012;29:25–37.
    1. Kemp J., Despres O., Sellal F., Dufour A. Theory of Mind in normal ageing and neurodegenerative pathologies. Ageing Res. Rev. 2012;11:199–219.
    1. Riley K.P., Snowdon D.A., Desrosiers M.F., Markesbery W.R. Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study. Neurobiol. Aging. 2005;26:341–347.
    1. Oulhaj A., Wilcock G.K., Smith A.D., de Jager C.A. Predicting the time of conversion to MCI in the elderly: role of verbal expression and learning. Neurology. 2009;73:1436–1442.
    1. Amieva H., Jacqmin-Gadda H., Orgogozo J.M., Le Carret N., Helmer C., Letenneur L., et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain. 2005;128:1093–1101.
    1. Bickart K.C., Wright C.I., Dautoff R.J., Dickerson B.C., Barrett L.F. Amygdala volume and social network size in humans. Nat. Neurosci. 2011;14:163–164.
    1. Reiman E.M., Langbaum J.B., Fleisher A.S., Caselli R.J., Chen K., Ayutyanont N., et al. Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J. Alzheimers Dis. 2011;26(3):321–329.
    1. Farias S.T., Mungas D., Reed B.R., Cahn-Weiner D., Jagust W., Baynes K., et al. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology. 2008;22:531–544.
    1. Zoller D.A., Kelly K.E., Amariglio E.R., Locascio J.J., Johnson A.K., Sperling A.R., et al. Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment. Curr. Alzheimer Res. 2014;11:853–861.
    1. Zoller A.S., Gaal I.M., Royer C.A., Locascio J.J., Amariglio R.E., Blacker D., et al. SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment. Curr. Alzheimer Res. 2014;11:785–791.
    1. Choi N.G., Hegel M.T., Marti N., Marinucci M.L., Sirrianni L., Bruce M.L. Telehealth problem-solving therapy for depressed low-income homebound older adults. Am. J. Geriatr. Psychiatry. 2014;22:263–271.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner